Aqua Bio Technology ASA (OSL:ABTEC)
Norway
· Delayed Price · Currency is NOK 0.496
-0.014 (-2.65%)
At close: Dec 5, 2025
Aqua Bio Technology ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 3.11 | 17.19 | 4.84 | 1.86 | 13.36 | 5.43 | Upgrade
|
| Short-Term Investments | - | - | 0.18 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 3.11 | 17.19 | 5.02 | 1.86 | 13.36 | 5.43 | Upgrade
|
| Cash Growth | -81.94% | 242.58% | 169.61% | -86.06% | 146.01% | -21.04% | Upgrade
|
| Accounts Receivable | 6.5 | 10.31 | 12.11 | 1.63 | 0.31 | 0.13 | Upgrade
|
| Other Receivables | - | 3.6 | 5.51 | 0.73 | 0.1 | 0.07 | Upgrade
|
| Receivables | 6.5 | 13.91 | 17.62 | 2.37 | 0.41 | 0.21 | Upgrade
|
| Inventory | 2.4 | 5.52 | 23.88 | 8.54 | 8.09 | 0.81 | Upgrade
|
| Other Current Assets | 0.19 | 0.97 | 2.32 | -0 | - | - | Upgrade
|
| Total Current Assets | 12.19 | 37.6 | 48.84 | 12.77 | 21.86 | 6.44 | Upgrade
|
| Property, Plant & Equipment | 1.3 | 43.22 | 17.15 | 0.27 | 0.29 | 0.53 | Upgrade
|
| Goodwill | - | 75.23 | 123.47 | 34.69 | 2.67 | 2.67 | Upgrade
|
| Other Intangible Assets | 6.81 | 92.18 | 41.12 | 16.13 | 5.88 | 6.6 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 3.35 | 3.74 | - | Upgrade
|
| Other Long-Term Assets | 0 | 1.48 | 7.16 | 0 | - | - | Upgrade
|
| Total Assets | 147.74 | 249.7 | 237.74 | 67.2 | 34.43 | 16.24 | Upgrade
|
| Accounts Payable | 16.04 | 45.41 | 36.03 | 3.34 | 2.28 | 0.99 | Upgrade
|
| Accrued Expenses | - | 19.97 | 10.09 | 2.83 | 0.93 | 0.7 | Upgrade
|
| Current Portion of Long-Term Debt | 107.54 | 92.2 | 22.84 | 15.89 | 7.12 | - | Upgrade
|
| Current Portion of Leases | 0.99 | 12.07 | 5.64 | 0.34 | - | - | Upgrade
|
| Current Income Taxes Payable | - | 1.59 | - | 0.01 | - | - | Upgrade
|
| Other Current Liabilities | 13.25 | 27.49 | 44.92 | 2.41 | 1.73 | 1.63 | Upgrade
|
| Total Current Liabilities | 137.83 | 198.73 | 119.51 | 24.82 | 12.06 | 3.33 | Upgrade
|
| Long-Term Debt | - | 52.7 | 9.34 | - | - | 0.89 | Upgrade
|
| Long-Term Leases | 0.48 | 48.3 | 14.9 | 0.67 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.38 | 18.45 | 7.37 | 2.32 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.91 | 13.25 | 0.85 | 37.53 | 3.67 | 3.7 | Upgrade
|
| Total Liabilities | 140.6 | 331.44 | 151.97 | 65.34 | 15.72 | 7.92 | Upgrade
|
| Common Stock | 272.13 | 272.13 | 118.54 | 51.68 | 51.56 | 46 | Upgrade
|
| Additional Paid-In Capital | - | 58.2 | 20.45 | - | - | - | Upgrade
|
| Retained Earnings | - | - | - | - | -32.82 | -37.65 | Upgrade
|
| Treasury Stock | -5.03 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | Upgrade
|
| Comprehensive Income & Other | -259.96 | -412.04 | -53.19 | -49.79 | - | - | Upgrade
|
| Shareholders' Equity | 7.14 | -81.74 | 85.78 | 1.86 | 18.71 | 8.32 | Upgrade
|
| Total Liabilities & Equity | 147.74 | 249.7 | 237.74 | 67.2 | 34.43 | 16.24 | Upgrade
|
| Total Debt | 109.02 | 205.28 | 52.71 | 16.91 | 7.12 | 0.89 | Upgrade
|
| Net Cash (Debt) | -105.92 | -188.08 | -47.69 | -15.04 | 6.23 | 4.54 | Upgrade
|
| Net Cash Growth | - | - | - | - | 37.34% | -33.99% | Upgrade
|
| Net Cash Per Share | - | -2.76 | -1.56 | -0.73 | 0.32 | 0.28 | Upgrade
|
| Filing Date Shares Outstanding | - | 108.84 | 55.22 | 20.66 | 20.61 | 18.39 | Upgrade
|
| Total Common Shares Outstanding | - | 108.84 | 55.22 | 20.66 | 20.61 | 18.39 | Upgrade
|
| Working Capital | -125.63 | -161.14 | -70.67 | -12.05 | 9.8 | 3.12 | Upgrade
|
| Book Value Per Share | - | -0.75 | 1.55 | 0.09 | 0.91 | 0.45 | Upgrade
|
| Tangible Book Value | 0.34 | -249.14 | -78.81 | -48.96 | 10.16 | -0.94 | Upgrade
|
| Tangible Book Value Per Share | - | -2.29 | -1.43 | -2.37 | 0.49 | -0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.